Daniel Stachel
Overview
Explore the profile of Daniel Stachel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heinz A, Calkoen F, Derbich A, Miltner L, Seitz C, Doering M, et al.
Haematologica
. 2023 Feb;
108(8):2080-2090.
PMID: 36794500
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the scalability...
2.
Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, et al.
Leukemia
. 2022 Sep;
36(11):2567-2576.
PMID: 36097283
Total body irradiation (TBI)-based conditioning is associated with superior leukemia-free survival in children with ALL undergoing HSCT. However, the risk for subsequent malignant neoplasms (SMN) remains a significant concern. We...
3.
Babor F, Peters C, Manser A, Glogova E, Sauer M, Potschger U, et al.
Bone Marrow Transplant
. 2019 May;
54(11):1847-1858.
PMID: 31089287
Although allogeneic hematopoietic stem-cell transplantation (HSCT) provides high cure rates for children with high-risk acute lymphoblastic leukaemia (ALL), relapses remain the main cause of treatment failure. Whereas donor killer cell...
4.
Penger T, Albrecht A, Marx M, Stachel D, Metzler M, Dorr H
Endocrinol Diabetes Metab Case Rep
. 2018 Jun;
2018.
PMID: 29899990
Learning Points: Endocrine sequelae after hematopoietic stem cell transplantation (HSCT) are common and can develop over a long period.Primary adrenal insufficiency after HSCT is absolutely rare.The combination of adrenal autoimmune...
5.
van den Bruck R, Weil P, Ziegenhals T, Schreiner P, Juranek S, Godde D, et al.
Mol Cell Pediatr
. 2017 May;
4(Suppl 1):5.
PMID: 28516419
No abstract available.
6.
Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Soder S, et al.
J Invest Dermatol
. 2016 Jul;
136(11):2150-2157.
PMID: 27375110
Severe generalized junctional epidermolysis bullosa, a lethal hereditary blistering disorder, is usually treated by palliative care. Allogeneic stem cell transplantation (SCT) has been proposed as a therapeutic approach, yet without...
7.
Stachel D, Stevens-Ayers T, Boeckh M
J Clin Virol
. 2016 Jan;
75:53-9.
PMID: 26780109
Background: Ganciclovir has demonstrated immunosuppressive effects in vitro which may lead to delayed cytomegalovirus (CMV)-specific immune reconstitution when the drug is given prophylactically. Maribavir is a new and more potent...
8.
Bader P, Kreyenberg H, von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, et al.
J Clin Oncol
. 2015 Jan;
33(11):1275-84.
PMID: 25605857
Purpose: To elucidate the impact of minimal residual disease (MRD) after allogeneic transplantation, the Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster Stem Cell Transplantation Group (ALL-BFM-SCT) conducted a prospective clinical trial. Patients And...
9.
Krumbholz M, Jung R, Bradtke J, Reinhardt D, Stachel D, Metzler M
Leuk Lymphoma
. 2014 Jun;
56(3):793-6.
PMID: 24884312
No abstract available.
10.
Lehmberg K, Albert M, Beier R, Beutel K, Gruhn B, Kroger N, et al.
Haematologica
. 2013 Oct;
99(1):180-4.
PMID: 24162790
In hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis, high transplant-related mortality after busulfan-based myeloablative regimens has been observed. Conditioning regimens with reduced toxicity based on melphalan or treosulfan are promising...